C4 Therapeutics, Inc.

NASDAQ:CCCC

Biotechnology

Healthcare
$2.48 +2.06%

+$0.08 today

Market cap
$325.01M
Beta
2.93
P/E (TTM)
-4.9
EPS (TTM)
-$0.82
52W Low $1.36High $4.60

Volume 2.75M

Average 2.76M

Price history

C4 Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-1.00%

Period high

$4.67

Period low

$1.71

Latest

$2.48

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 13, 2026Nov 13, 2026
8-KNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
8-KSep 25, 2026Sep 25, 2026
4Sep 21, 2026Sep 21, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 12, 2026Aug 12, 2026
8-KAug 11, 2026Aug 11, 2026
10-QAug 11, 2026Aug 11, 2026
SC 13GJul 27, 2026Jul 27, 2026
4Jul 13, 2026Jul 13, 2026

Competitors

Who does C4 Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CCCC's filings, answered from its disclosures.

What is the latest CCCC filing?

The latest filing shown is 4 dated Nov 13, 2026.

How many recent filings does CCCC have?

Intrinsic Alpha currently shows 20 recent filings for CCCC.